Norges Bank’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $136M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $152M | Buy |
|
|||||
|
2024
Q3 | $152M | Buy |
|
|||||
|
2024
Q2 | $12.4M | Sell |
|
|||||
|
2024
Q1 | $107M | Buy |
|
|||||
|
2023
Q4 | $101M | Buy |
|
|||||
|
2023
Q3 | $98.9M | Buy |
|
|||||
|
2023
Q2 | $89.4M | Buy |
|
|||||
|
2023
Q1 | $88.7M | Sell |
|
|||||
|
2022
Q4 | $124M | Buy |
|
|||||
|
2022
Q3 | $87.9M | Buy |
|
|||||
|
2022
Q2 | $96.1M | Sell |
|
|||||
|
2022
Q1 | $74.7M | Sell |
|
|||||
|
2021
Q4 | $93.3M | Buy |
|
|||||
|
2021
Q3 | $76.7M | Sell |
|
|||||
|
2021
Q2 | $75.6M | Sell |
|
|||||
|
2021
Q1 | $80M | Buy |
|
|||||
|
2020
Q4 | $58.9M | Sell |
|
|||||
|
2020
Q3 | $40.9M | Sell |
|
|||||
|
2020
Q2 | $53.1M | Sell |
|
|||||
|
2020
Q1 | $50M | Hold |
|
|||||
|
2019
Q4 | $46.5M | Buy |
|
|||||
|
2019
Q3 | $41M | Buy |
|
|||||
|
2019
Q2 | $38.9M | Hold |
|
|||||
|
2019
Q1 | $58.5M | Hold |
|
|||||
|
2018
Q4 | $54.2M | Buy |
|
|||||
|
2018
Q3 | $58M | Hold |
|
|||||
|
2018
Q2 | $51.3M | Hold |
|
|||||
|
2018
Q1 | $51M | Hold |
|
|||||
|
2017
Q4 | $67.1M | Buy |
|
|||||
|
2017
Q3 | $49.7M | Buy |
|
|||||
|
2017
Q2 | $49.3M | Buy |
|
|||||
|
2017
Q1 | $46.3M | Sell |
|
|||||
|
2016
Q4 | $64M | Buy |
|
|||||
|
2016
Q3 | $50M | Sell |
|
|||||
|
2016
Q2 | $47.7M | Sell |
|
|||||
|
2016
Q1 | $51.6M | Buy |
|
|||||
|
2015
Q4 | $66M | Buy |
|
|||||
|
2015
Q3 | $50.6M | Hold |
|
|||||
|
2015
Q2 | $67.1M | Sell |
|
|||||
|
2015
Q1 | $69.6M | Sell |
|
|||||
|
2014
Q4 | $55.2M | Buy |
|
|||||
|
2014
Q3 | $50.8M | Sell |
|
|||||
|
2014
Q2 | $58.6M | Buy |
|
|||||
|
2014
Q1 | $28.2M | Hold |
|
|||||
|
2013
Q4 | $33.9M | Buy |
|
|||||
|
2013
Q3 | $22.7M | Buy |
|
|||||
|
2013
Q2 | $13.3M | Buy |
|